Design Therapeutics, Inc.DSGNNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+13.2%/yr
Quarterly compound
Percentile
P83
Within normal range
vs 3Y Ago
1.5x
Solid growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.00% |
| Q3 2025 | 11.76% |
| Q2 2025 | -9.68% |
| Q1 2025 | -29.17% |
| Q4 2024 | -4.35% |
| Q3 2024 | -9.52% |
| Q2 2024 | -5.00% |
| Q1 2024 | 4.76% |
| Q4 2023 | 25.00% |
| Q3 2023 | 22.22% |
| Q2 2023 | -20.00% |
| Q1 2023 | -11.11% |
| Q4 2022 | 6.90% |
| Q3 2022 | -11.54% |
| Q2 2022 | -8.33% |
| Q1 2022 | -20.00% |
| Q4 2021 | 4.76% |
| Q3 2021 | -50.00% |
| Q2 2021 | 54.84% |
| Q1 2021 | -121.43% |
| Q4 2020 | -64.13% |
| Q3 2020 | -60.94% |
| Q2 2020 | -117.21% |
| Q1 2020 | 0.00% |